Imatinib Recruiting Phase 1 / 2 Trials for ALK+ Anaplastic Large Cell Lymphoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs